Anti-PRSS8 antibody (ab203879)
Key features and details
- Rabbit polyclonal to PRSS8
- Suitable for: IHC-P
- Reacts with: Human
- Isotype: IgG
Overview
-
Product name
Anti-PRSS8 antibody
See all PRSS8 primary antibodies -
Description
Rabbit polyclonal to PRSS8 -
Host species
Rabbit -
Tested Applications & Species
See all applications and species dataApplication Species IHC-P Human
-
Immunogen
Synthetic peptide within Human PRSS8 aa 50-150 conjugated to keyhole limpet haemocyanin. The exact immunogen sequence used to generate this antibody is proprietary information. If additional detail on the immunogen is needed to determine the suitability of the antibody for your needs, please contact our Scientific Support team to discuss your requirements.
Database link: Q16651
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.2
Preservative: 0.09% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 0.01% BSA -
Concentration information loading... -
Purity
Protein A purified -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Images
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRSS8 antibody (ab203879)
Immunohistochemical analysis of formalin-fixed paraffin-embedded Human lung carcinoma tissue, labeling PRSS8 using ab203879 at a 1/200 dilution, followed by conjugation to the secondary antibody and DAB staining.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRSS8 antibody (ab203879)Immunohistochemical analysis of formalin-fixed paraffin-embedded Human kidney tissue, labeling PRSS8 using ab203879 at a 1/200 dilution, followed by conjugation to the secondary antibody and DAB staining.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRSS8 antibody (ab203879)Immunohistochemical analysis of formalin-fixed paraffin-embedded Human prostate cancer tissue, labeling PRSS8 using ab203879 at a 1/200 dilution, followed by conjugation to the secondary antibody and DAB staining.
